Indonesian Political, Business & Finance News

Economic Burden of Dengue in Indonesia Reaches Rp9 Trillion, Vaccination Emerges as Strategic Solution

| | Source: Media Indonesia Translated from Indonesian | Economy
Economic Burden of Dengue in Indonesia Reaches Rp9 Trillion, Vaccination Emerges as Strategic Solution
Image: Media Indonesia

Dengue is no longer merely a public health threat but has transformed into a significant national economic burden. According to recent research presented at the 9th Asia Dengue Summit in Singapore in June 2026, the total economic loss due to dengue in Indonesia in 2024 is estimated to reach US$550.9 million, or the equivalent of nearly Rp9 trillion.

This staggering figure includes more than 2 million hospital visits, which place immense pressure on the healthcare system. Without systematic control, there are concerns that surges in dengue cases could hinder the national economic growth target of 8% by 2029.

A study from the Centre for Health Financing Policy and Insurance Management (Pusat KPMAK) at Gadjah Mada University (UGM) reveals a crucial fact: although most patients are covered by BPJS Kesehatan through the National Health Insurance (JKN), the financial burden on households remains high.

Dr Diah Ayu Puspandari, a senior researcher at UGM, explained that JKN has not yet fully eliminated the economic burden on families. Patients still have to bear non-medical costs such as transport, meals for caregivers, and lost income due to inability to work.

In response to this high burden, a study from the Centre for Child Health (CCH-PRO) at UGM shows that dengue vaccination programmes for school-aged children represent a highly cost-effective intervention. In the long term (20 years), vaccination is projected to prevent the loss of 1.1 to 1.3 million healthy life years (DALY).

From a broader societal perspective, investment in prevention could yield net savings of between USD 329.3 million and USD 731.5 million due to reduced productivity losses and school absenteeism.

The Koalisi Bersama (KOBAR) Lawan Dengue (Coalition to Fight Dengue) is pushing for integrated prevention to become a national priority. The Chairman of KOBAR Lawan Dengue, Dr H. Suir Syam, emphasised the importance of viewing prevention as a long-term investment for the nation.

The government, through the Deputy Minister of Health, Dr Benjamin Paulus Octavianus, has expressed commitment to achieving ‘Zero Dengue Deaths 2030’. Currently, the Ministry of Health is drafting the National Action Plan (RAN) for Dengue Control 2026–2029.

This initiative is also supported by the business community through KADIN (the Indonesian Chamber of Commerce and Industry), which views health as the fundamental foundation of labour productivity and national economic competitiveness. Through collaboration between the government, academia, and the public, Indonesia is expected to be able to break the chain of dengue transmission and strengthen national health resilience.

More from 17 September 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/economic-burden-of-dengue-in-indonesia-reaches-rp9-trillion-vaccination-emerges-as-strategic-solution-1789624520)
Originally published by Media Indonesia (https://mediaindonesia.com/kesehatan/934379/beban-ekonomi-dengue-di-indonesia-capai-rp9-triliun-vaksinasi-jadi-solusi-strategis), translated from Indonesian
Print